Thursday, March 24, 2022 at 11am EST | 10am CST | 8am PST Advancing size-exclusion chromatography through recent developments in particle technology and hydrophilic surfaces.
Register Free: https://www.biopharminternational.com/bp_w/particle
Improvements in size-exclusion chromatography (SEC) particle technologies in the last decade have given scientists a wide selection of high efficiency SEC columns. As SEC columns have asymptotically approached maximum plate counts at reasonable operating pressures, the most significant improvements to be gained for these separations are improvements in the inertness of not only the packed particles but also the column hardware. This presentation will review how new hydrophilic surfaces combined with advances in particle technology result in significantly decreased non-desired interactions with proteins and other biomolecules, specifically:
Key Learning Objectives:
Who Should Attend:
Lab scientists involved in the development or deployment of SEC separations for the analyses of proteins, conjugated protein, other biomolecules, or macromolecules prone to ionic or hydrophobic interactions.
Stephan M. Koza, PhD, consulting scientist for Waters Corporation, has worked at Waters Corporation for nine years and leads an applications group that focuses on the use of LC, LC-MS[MR1], and sample preparation chemistries and columns for the analysis of biomolecules. Prior to Waters, Stephan worked with Genetics Institute, Wyeth, and Pfizer on biopharmaceutical characterization and analytical method development.
Register free: https://www.biopharminternational.com/bp_w/particle